Compare LONA & TOUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LONA | TOUR |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.7M | 55.2M |
| IPO Year | 2020 | 2014 |
| Metric | LONA | TOUR |
|---|---|---|
| Price | $4.35 | $4.72 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $16.67 | N/A |
| AVG Volume (30 Days) | ★ 82.9K | 3.9K |
| Earning Date | 11-17-2026 | 12-04-2026 |
| Dividend Yield | N/A | ★ 25.31% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $5.00 |
| Revenue Next Year | N/A | $3.00 |
| P/E Ratio | ★ N/A | $87.34 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.21 | $0.56 |
| 52 Week High | $14.21 | $7.79 |
| Indicator | LONA | TOUR |
|---|---|---|
| Relative Strength Index (RSI) | 39.17 | 41.24 |
| Support Level | $4.39 | $4.71 |
| Resistance Level | $9.78 | $5.31 |
| Average True Range (ATR) | 0.45 | 0.09 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 2.87 | 30.77 |
LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.
Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. The company offers a large selection of packaged tours, including organized tours and self-guided tours, and travel-related services for leisure travellers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. The company derives almost all of its revenue from PRC.